355 DISEASE MODIFYING DRUGS IN KNEE OSTEOARTHRITIS: CAN THEY BE COST-EFFECTIVE?
نویسندگان
چکیده
منابع مشابه
Drugs for Alzheimer's disease: are they effective?
OVERVIEW AD is a neurodegenerative process marked by neuronal loss and the deposition of abnormal proteins in the form of amyloid plaques and neurofibrillary tangles. Beta-amyloid deposition culminates in the production of extracellular amyloid plaques in the cerebral cortex and elsewhere in the central nervous system (CNS). Hyperphosphorylation of the intracellular tau protein results in neuro...
متن کاملNew targets for disease modifying osteoarthritis drugs: chondrogenesis and Runx1.
Osteoarthritis (OA) has recently been defined as a ‘whole joint’ disease with pathological changes in all tissues, including articular cartilage degradation, subchondral bone thickening, osteophyte formation, synovial inflammation and degeneration of ligaments, and, in the knee, the menisci. OA is a chronic musculoskeletal disease that leads to pain and severe impairment of mobility. OA is the ...
متن کاملCan traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis?
Psoriatic arthritis (PsA) is a complex, multisystem disease with musculoskeletal and skin manifestations frequently associated with features of the metabolic syndrome. For many years, treatment strategies were largely borrowed from the rheumatoid arthritis literature, with clinical trials of traditional DMARDs in PsA often inadequate and using limited outcome measures. Nonetheless, DMARDs - in ...
متن کاملcost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in iran.
background: disease-modifying drugs (dmds) are a significant expenditure for treating multiple sclerosis (ms). however, there is limited report on assessment of the cost-utility of dmds compared with symptom management in the presence of long-term data. this study aimed to assess the lifetime cost-utility from the iranian healthcare perspectives of 4dmds relative to symptom management alone in ...
متن کاملAre biologics more effective than classical disease-modifying antirheumatic drugs?
Major achievements have been reached in the treatment of rheumatoid arthritis during past decades due to the recognition of methotrexate as an anchor drug for treatment of rheumatoid arthritis, due to the notion of a treatment window of opportunity in patients with recent-onset rheumatoid arthritis necessitating early aggressive therapy, due to the development of biologics and due to remission ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Osteoarthritis and Cartilage
سال: 2009
ISSN: 1063-4584
DOI: 10.1016/s1063-4584(09)60377-0